Patient Characteristics (n = 200)
| Characteristic | Frequency | Mean ± SD | Median | Interquartile range |
| Age (y) | 69 ± 8 | 70 | 64–74 | |
| Weight (kg) | 80 ± 11 | 79 | 72–87 | |
| BMI | 26.7 ± 4 | 26.2 | 24.0–29.0 | |
| Injected activity (MBq) | 160 ± 21 | 157 | 150–174 | |
| Uptake time (min) | 73 ± 13 | 70 | 65–82 | |
| PSA PET (ng/mL) | 10.4 ± 72.9 | 0.9 | 0.4–2.2 | |
| Clinical indication | ||||
| Primary staging | 7/200 (4%) | |||
| Biochemical recurrence | 168/200 (84%) | |||
| Castration-resistant PCa | 25/200 (12%) | |||
| PET device | ||||
| Discovery 710 | 78/200 (39%) | |||
| Discovery STE | 122/200 (61%) |